Clinical Trial Update: Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating sipuleucel-T in combination with Bipolar Androgen Therapy for metastatic castration-resistant pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Bipolar androgen therapy
• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Yale University | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 2 | Status: RECRUITING